---
schema_version: "secwatch.filing_event.v1"
accession: "0001051514-23-000003"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:27:33.471422+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# STRATA inks exclusive Mexico distribution deal; targets $300M acne, psoriasis, vitiligo market

## Summary
- Three-year exclusive agreement with MINO Labs for distribution of TheraClearX, VTRAC, and XTRAC in Mexico.
- STRATA gains access to nearly $300 million market for acne, psoriasis, and vitiligo treatments.
- 80% of Mexico's population is affected by low to severe acne, according to the release.
- MINO Labs brings 20 years of pharmaceutical industry experience and deep Central/Latin America expertise.

## SEC filing metadata
- accession: 0001051514-23-000003
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000105151423000003/0001051514-23-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000105151423000003/form_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001051514-23-000003
- JSON: https://secwatch.observer/filing/0001051514-23-000003.json
- Plain text: https://secwatch.observer/filing/0001051514-23-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.